Masters Capital Management LLC Inmune Bio, Inc. Call Options Transaction History
Masters Capital Management LLC
- $2.51 Billion
- Q2 2025
Call Options
1 transactions
Others Institutions Holding INMB
# of Institutions
94Shares Held
6.28MCall Options Held
1.51MPut Options Held
3.34M-
Vanguard Group Inc Valley Forge, PA848KShares$1.51 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.45 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.06 Million45.87% of portfolio
-
Ubs Group Ag449KShares$799,6130.0% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$694,0770.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $31.9M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...